- Home
- CLH vs ASND Comparison
CLH vs ASND Comparison
Compare CLH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- ASND
- Stock Information
- Founded
- CLH 1980
- ASND 2006
- Country
- CLH United States
- ASND Denmark
- Employees
- CLH N/A
- ASND 1017
- Industry
- CLH Environmental Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CLH Industrials
- ASND Health Care
- Exchange
- CLH Nasdaq
- ASND Nasdaq
- Market Cap
- CLH 12.7B
- ASND 12.1B
- IPO Year
- CLH 1987
- ASND 2015
- Fundamental
- Price
- CLH $237.22
- ASND $199.37
- Analyst Decision
- CLH Strong Buy
- ASND Strong Buy
- Analyst Count
- CLH 9
- ASND 16
- Target Price
- CLH $256.56
- ASND $240.75
- AVG Volume (30 Days)
- CLH 319.8K
- ASND 370.3K
- Earning Date
- CLH 10-29-2025
- ASND 11-13-2025
- Dividend Yield
- CLH N/A
- ASND N/A
- EPS Growth
- CLH N/A
- ASND N/A
- EPS
- CLH 7.11
- ASND N/A
- Revenue
- CLH $5,942,342,000.00
- ASND $576,332,355.00
- Revenue This Year
- CLH $3.75
- ASND $102.31
- Revenue Next Year
- CLH $5.47
- ASND $76.44
- P/E Ratio
- CLH $33.43
- ASND N/A
- Revenue Growth
- CLH 5.49
- ASND 54.50
- 52 Week Low
- CLH $178.29
- ASND $118.03
- 52 Week High
- CLH $267.11
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- CLH 47.45
- ASND 57.01
- Support Level
- CLH $231.44
- ASND $193.00
- Resistance Level
- CLH $239.06
- ASND $200.55
- Average True Range (ATR)
- CLH 4.78
- ASND 5.87
- MACD
- CLH -0.71
- ASND -0.85
- Stochastic Oscillator
- CLH 36.70
- ASND 48.20
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.